Trimetazidine Attenuates Heart Failure by Improving Myocardial Metabolism via AMPK.

导出 LinkOut

翻译打印收藏纠错

第一作者： Hongyang,Shu

第一单位： Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

作者： Hongyang,Shu ^[1] ; Weijian,Hang ^[2] ; Yizhong,Peng ^[1] ; Jiali,Nie ^[2] ; Lujin,Wu ^[3] ; Wenjun,Zhang ^[1] ; Dao Wen,Wang ^[2] ; Ning,Zhou ^[1]

作者单位： Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. ^[1] Hubei Key Laboratory of Genetics and Molecular Mechanism of Cardiologic Disorders, Huazhong University of Science and Technology, Wuhan, China. ^[2] Department of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. ^[3]

关键词 AMPK heart failure myocardial metabolism pressure overload trimetazidine

DOI 10.3389/fphar.2021.707399

PMID 34603021

发布时间 2021-10-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in pharmacology

2021年12卷

707399页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Trimetazidine Attenuates Heart Failure by Improving Myocardial Metabolism via AMPK.

Frontiers in pharmacology

相似文献

Frontiers in pharmacology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Trimetazidine Attenuates Heart Failure by Improving Myocardial Metabolism via AMPK.

Frontiers in pharmacology

相似文献

Frontiers in pharmacology

相关期刊

检索历史清除